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ABSTRACT   
 
Objective: To investigate the possible effects of middle and high school racial composition on later reporting of 
lifetime non-medical use of prescription painkillers (NMUPP) in young adulthood, and to explore whether there 
is evidence of variability by individual race/ethnicity in such effects.  
 
Methods: Using data from Wave 1 (1994/5) of the National Longitudinal Study of Adolescent to Adult Health 
(Add Health), we categorized the sample’s 52 middle schools and 80 high schools as majority (>50%) non-
Hispanic white, majority non-Hispanic black, or neither. We used two-level hierarchical modelling to explore 
associations between individual- and school-level race at Wave 1 and lifetime prescription painkiller misuse 
reported at Wave 4. We included a cross-level interaction between individual race and school racial 
composition to assess variability in school-level associations by race. 
 
Results: Overall crude prevalence of lifetime NMUPP in majority white schools (17.9%) was over three times 
that of prevalence in majority black schools (4.8%), and also higher than prevalence in schools neither 
predominantly black nor predominantly white (12.4%). Lifetime misuse among blacks in majority white 
schools was more prevalent (5.2%) than among blacks in black schools (2.8%), as was misuse among whites in 
white schools (19.3%) compared to their white peers in black schools (15.7%). Two-level random intercept 
Poisson regression results suggest that attendance in a majority black secondary school lowered a participant’s 
risk of lifetime NMUPP (compared to attending majority white school: Model 3, RR=0.66, p=0.03). Compared 
to blacks in black schools, blacks in white schools had twice the risk of prescription painkiller misuse (p=0.004) 
over a decade later, and whites in white schools had 5.5 times the risk (p=0.01). The risk ratio comparing whites 
in black schools to whites in white schools was not significant (RR: 1.30; p=0.37). 
 
Conclusions: We found evidence of an effect of school racial composition on the risk of misusing prescription 
painkillers over a decade later, over and above individual race, with higher risk of misuse reported among 
participants who had attended white schools. Black participants who had attended predominantly white schools 
were, on average, twice as likely to report lifetime misuse of prescription painkillers compared to blacks who 
had attended black schools. 
 
 
 
Keywords: prescription painkiller substance race multilevel add health 
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Introduction  
Remarkably consistent variability by race and ethnicity in substance use has been observed in the U.S., with 
highest rates reported among non-Hispanic whites across substances such as cigarettes, alcohol, marijuana, and 
other illicit drugs [1]. Similar disparities have emerged in the rise of misuse of prescription medications, 
including the nonmedical use of prescription painkillers (NMUPP). In one large, nationally representative cross-
sectional study, non-Hispanic white participants aged 12 to 17 were more likely to report non-medical use of 
opioids (10.5%) than were Hispanics (9.4%) or non-Hispanic blacks (8.9%) [2]. Studies involving college 
students also show higher prevalence of misuse of prescription drugs among whites than among racial and 
ethnic minority groups [3]. Similar patterns—with an often more pronounced relative protection for blacks—
have continued to surface for adolescents and young adults in recent years [4, 5].  
The mechanisms underlying this consistent variability by race are not fully known, but a protective 
effect for blacks and Hispanics—for prescription drug misuse in particular—might arise from the well-
documented disparities in prescribing by doctors, who in multiple studies have been shown to treat pain 
differentially by race of patients, with far higher prescribing rates for non-Hispanic whites compared to 
minorities [6-8]. Compounding this disparity is the striking difference in the stocking of opioids in pharmacies, 
with facilities in minority neighborhoods often understocked, while pharmacies in white neighborhoods carry 
more adequate quantities of the demanded painkillers [9, 10]. There is also some evidence that religiosity might 
have a protective influence against substance use [11, 12] by acting as a buffer against stress [13]. Such 
protection could be more prevalent among blacks and Hispanics, who are more likely to report being religious 
[14, 15]. A so-called “immigrant effect” might be an alternative explanation for lower rates of drug use among 
Hispanics, who are more likely to be immigrants, a status that has repeatedly been linked to lower rates of 
cigarette, alcohol, and other illicit substance use [16-21].  
While the literature on the topic has grown along with the opioid epidemic, researchers have noted the 
dearth of longitudinal studies examining factors tied to the non-medical use of prescription drugs, due to a 
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heavy reliance on cross-sectional data [22, 23]. As the lifecourse perspective emphasizes, exposures at 
formative times (e.g., adolescence) can exert significant and enduring influence on health outcomes throughout 
the lifespan [24-26], making longitudinal studies crucial to our understanding of disease patterns. Explorations 
of the roots of prescription drug misuse would also benefit from the inclusion of school-level characteristics, as 
previous work has revealed the critical role the school environment can have on shaping the risk-taking 
behaviors of adolescents and young adults [27-36]. Given the differences reported by individual race in 
prescription drug misuse, a worthy focal point for investigation of higher-level measures would be racial 
composition at the school level, and its potential influence on prevalence of prescription painkiller misuse, 
above and beyond the role of individual race and ethnicity. Research has shown the powerful influence of the 
school environment in introducing adolescents to behavioral modeling, social norms of peers, and increased 
access to substances [27-30]. Evidence suggests substance use varies significantly across schools for smoking 
[31-33], drinking [34], and marijuana use [35]. Because early initiation of substance use in adolescence predicts 
misuse later in life [29, 36], it is particularly important to explore any lasting associations between school 
environment and prescription misuse evident in adulthood. 
The aim of this study is to determine whether an association exists between non-medical use of 
prescription painkillers and school-level racial composition, over and above any relationship between NMUPP 
and individuals’ race, and whether such a relationship varies by individual race. This preliminary exploration is 
motivated by at least four hypothesized mechanisms explaining possible disparities by race at the school level. 
First, it is known that schools affect behavior of adolescent students by establishing and reinforcing social and 
behavioral norms [29, 37]. Social influence theory highlights teens’ desire to conform to group norms in 
behavior and attitude [38]. A majority-white school setting where prevalence of substance use is likely to 
already be elevated might therefore lead to further reinforcement and perpetuation. 
Alternatively, health disparities by school racial composition might be explained by the effects that 
segregated settings could have on psychosocial pathways. Minority students in majority white schools 
experience more racial discrimination and harassment [39]; such experiences can lead to social disengagement 
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[40]. Higher rates of substance use have been seen among teens reporting feeling of disconnection from their 
schools [41]. Substance use has also been seen to be a coping mechanism for the stress that discrimination 
causes [42-44]. Minority students in high-percentage white schools, therefore, might be more at risk for 
substance use, including NMUPP. 
Third, school-level variation in substance use could stem from differences in school regulations. Schools 
with tighter regulations and policies regarding punitive repercussions of illicit substance use, it might be argued, 
could see lower rates of drug use; the same might be true in schools with programs promoting social norms 
discouraging such behavior. However, evidence suggests that such policies have more of an impact on overt 
behavior as opposed to covert behavior [45]; their effectiveness, therefore, might be far greater for an activity 
like smoking than for a behavior like swallowing a pill, which is easier to conceal. 
A fourth possible mechanism involves the practical matter of access. As noted above, non-Hispanic 
whites are most likely to be prescribed painkillers [6]. Pharmacies serving minority populations have been seen 
to be severely understocked with opioid analgesics compared to pharmacies in white neighborhoods [9, 10]. 
The most common source of diverted prescription medications for misuse among teens and young adults is 
friends and family [46, 47]. These facets of access could work in concert to ensure that NMUPP would be most 
prevalent in schools with high percentages of white students, where prescriptions would be more abundant.  
To our knowledge, there has yet to be a study assessing the influence that school-level racial 
composition in adolescence might have on misuse of prescription painkillers reported in early adulthood. This 
gap is unsurprising, as most work on health effects of segregated settings has focused on segregation at the 
neighborhood level [48]. Recent exceptions include work by Bifulco et al. [49], who found evidence of 
increased marijuana use among students in high-percentage-black school cohorts but no significant effects for 
post-secondary outcomes. Walsemann and colleagues [50] reported that depressive symptoms among blacks 
increased as the percentage of white students in schools they had attended rose. Results of work by Goosby and 
Walsemann [51] exposed a harmful association for blacks between previous attendance in a predominantly 
white school and self-rated health in young adulthood.  
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Exploiting the rich longitudinal data from Add Health, we follow students who attended middle and high 
schools of different racial compositions to see whether there is evidence of an enduring association between 
school-level racial composition in adolescence and lifetime non-medical use of prescription painkillers reported 
in young adulthood. Using hierarchical regressions that include cross-level interactions, we run the rough 
equivalent of a fictitious experiment to see if any variability in effect estimates for school context vary by 
race/ethnicity among our sample population. We hypothesize that higher prevalence of lifetime NMUPP in 
young adulthood will be seen among study participants who attended majority white schools compared to those 
who went to majority black or neither majority schools in adolescence, and that this association will be 
significant, even after adjustment for individual-level race. We also predict that blacks who attended white 
schools will be at increased risk of NMUPP compared to blacks who were in black schools in their teen years, 
while whites who attended predominantly black schools will be less likely to report misuse in adulthood. 
Methods  
Sample 
Data come from the National Longitudinal Study of Adolescent to Adult Health (Add Health), an ongoing, 
nationally representative sample of students from 132 schools in the U.S. (80 high schools and 52 feeder 
schools) [52]. Systematic sampling methods and implicit stratification in its sample design ensure that the Add 
Health sample is representative of U.S. schools with respect to region of country, urbanicity, school size, school 
type, and ethnicity.  
Add Health began in 1994, with four instruments used in its first wave (Wave I, conducted from 
September of 1994 through December of 1995); two surveys used in Wave II (conducted from April through 
August of 1996); multiple sources in Wave III (August 2001 through April of 2002); and one in-home survey 
conducted in Wave IV (January of 2008 through February of 2009). Wave V data collection is underway as of 
March 2017. According to the University of North Carolina, where it is administered, “Add Health is the 
largest, most comprehensive longitudinal survey of adolescents ever undertaken.” Instruments include in-school 
questionnaires, as well as in-home interviews of not only the students themselves, but also their parents and 
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siblings. Other data are collected from school administrators, fellow students, and romantic partners of the 
students surveyed. Add Health also includes contextual variables garnered from pre-existing databases.  
The initial in-school questionnaire was administered to 90,118 students in grades 7 through 12 in the 
1994-1995 academic year. Of these 90,118 students, 20,745 were then given more involved at-home surveys, 
and were re-interviewed in the following Waves. Approximately 15,000 participants were interviewed at both 
Wave 1 and Wave 3, as well as at both Wave 1 and Wave 4. The majority of participants in the survey were 
aged 18 to 26 years old at Wave 3, and 24 to 32 years old at Wave 4. Add Health collects information on 
respondents’ demographic, social, and behavioral characteristics, along with (more recently) certain biomedical 
samples. 
 The sample for this analysis was restricted to those respondents completing in-home surveys at both 
Waves 1 and 4 (n=15,701). Participants missing parental income data from the parent questionnaire (Wave 1) 
were excluded (2,371 missing and 1,328 whose parents refused to report income), as were those missing 
information on race (n=19). Seventeen additional respondents were dropped for missing outcome, and three 
more were excluded for missing age data, leaving an analytic sample of 11,602. 
Measures 
Nonmedical Use of Prescription Painkillers 
The primary outcome for this study was self-reported lifetime non-medical misuse of prescription painkillers 
(NMUPP). In the in-home survey at Wave 4 in 2008, participants were asked a series of questions about 
substance use, including non-medical use of prescription drugs. The first of these questions assessed lifetime 
non-medical use of any kind of prescribed drug: “Have you ever taken any prescription drugs that were not 
prescribed for you, taken prescription drugs in larger amounts than prescribed, more often than prescribed, for 
longer periods than prescribed, or taken prescription drugs that you took only for the feeling or experience they 
caused?” Respondents answering “yes” were then instructed to report on specific types of prescription drugs: 
sedatives, tranquilizers, stimulants, and painkillers. Our binary outcome measure is based on responses to the 
question capturing painkiller misuse: “Which of the following types of prescription drugs have you taken that 
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were not prescribed for you, taken in larger amounts than prescribed, more often than prescribed, for longer 
periods than prescribed, or that you took only for the feeling or experience they caused? (check all that apply)… 
pain killers or opioids, such as Vicodin, OxyContin, Percocet, Demerol, Percodan, or Tylenol with codeine.” 
For those responding affirmatively, the outcome variable NMUPP was coded “1”; for all others, the variable 
was coded “0.”  
 
Race and Ethnicity at the Individual and School Levels 
Our independent variables of interest (individual race/ethnicity and school-level racial composition) come from 
respondents’ self-reported primary race at the Wave 1 1994/1995 in-home survey. We categorized respondents 
as non-Hispanic white, non-Hispanic black, Hispanic, and all other non-Hispanic (“other”). From this 
individual-level measure of race/ethnicity we then constructed our variable for each school’s racial composition 
by calculating their respective populations’ percentages of non-Hispanic whites and of non-Hispanic blacks. 
Schools with >50% non-Hispanic white students were categorized as “majority white,” with >50% non-
Hispanic black “majority black,” and the remaining schools “neither.” Wave 1 grand sampling probability 
weights were used in aggregating data to ensure that numbers were representative of schools’ actual 
populations. The in-home survey was chosen rather than the larger in-school data due to evidence of substantial 
race/ethnicity reporting bias [50]. Using the in-home data as a source of racial composition has resulted in 
measures highly correlated with available Common Core administrative information on a portion of the Add 
Health high schools (correlation of 0.99) [50]. 
 
Individual-Level Covariates 
Participant demographic characteristics were taken from data collected at Wave 1. Both sex and age have been 
shown to significantly predict non-medical use of prescription drugs [23, 53-55]. Other potential individual-
level confounders of interest include parental educational attainment and family household income. Parental 
education was measured as the higher of maternal or paternal education level reported in the Wave 1 parental 
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questionnaire, and categorized as less than high school; high school; some college; college; or more than 
college.  
Socioeconomic status in adolescence was also captured using family pre-tax income at Wave 1. The 
measure was derived from parental reports of total pre-tax family income (in $1000-increments, top-coded at 
$999,000) given by parents of respondents at Wave I in the separate parent questionnaire administered in 1994. 
The measure was equivalized for household size by dividing the reported total family income figure by the 
square root of the number of household members. The sample was then divided into quartiles based on 
participants’ values for this variable.  
 
School-Level Covariates 
We adjust for the following possibly confounding factors at the school level: region of country (West, Midwest, 
South, Northeast); school size (small, medium, or larger); and school type (private vs public). To explore the 
possible contextual effect of school-level SES, for supplemental analyses we created a dichotomous variable for 
low- versus high-income schools, using as a cut-off the median of the medians of family income across all 
schools.  
 
Statistical Analysis 
Initial analyses were conducted using SAS version 9.4 (SAS Institute; Cary, NC) and multilevel analyses were 
done in STATA 14.2. Overall crude prevalence of lifetime painkiller misuse was first calculated for the full 
sample (n=11,602), and then for each of the three categories of school (majority NHW, majority NHB, and 
neither). Both unweighted and weighted prevalence estimates were calculated. The sample was stratified by 
race/ethnicity to determine the crude proportion of NMUPP for each subset of race category within the three 
types of schools. Additional stratification was done by school-level SES (family income) at Wave 1 to assess 
prevalence based on that level-2 measure.  
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In addition to these assessments of crude proportion of reported lifetime non-medical prescription 
painkiller misuse, we ran two-level random intercept Poisson regressions to assess the risk of lifetime NMUPP 
by race and by school characteristics. In order to test for variability by race/ethnicity in contextual school-based 
effects, we included interaction terms between level-one individual race and level-two school-wide racial 
composition. 
Results 
School Racial Composition 
Table 1 displays the breakdown of school-level racial composition for our Add Health sample schools at Wave 
1. Of the 132 schools, the majority (n=88) had student populations that were over 50% non-Hispanic white at 
Wave 1. Only 14 schools were majority non-Hispanic black. The remainder (n=30) had neither >50% black 
populations nor >50% white populations.  
 
Crude Prevalence of NMUPP in Young Adulthood by School Type Attended  
As seen in Table 1, at Wave 4, 15.8% of the full sample reported lifetime misuse of prescription painkillers. 
Prevalence of misuse of these prescription drugs was higher among non-Hispanic whites than among non-
Hispanic blacks: 19.4% vs 4.2%, respectively, and was 9.5% for Hispanic participants. The proportion of young 
adults reporting painkiller misuse was highest among those who had attended predominantly white schools in 
adolescence: 17.9%. This fraction was nearly 4 times larger than the proportion of those reporting misuse who 
had attended predominantly black schools in their teen years (4.8%) and was also higher than the percentage 
reporting NMUPP who had attended neither majority black nor majority white schools (12.4%). Results of a 
Pearson’s chi-square test showed these differences to be statistically significant (p<0.0001). 
Further breakdown within each of the three different categories of schools attended reveals that non-
Hispanic white individuals consistently had the highest proportions of reported NMUPP, regardless of school 
racial composition: 19.3% (whites from white schools), 15.7% (whites from black schools), and 21.5% (whites 
from neither type of school). Non-Hispanic black participants had much lower proportions, though misuse was 
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more prevalent among those who had gone to majority white schools (5.2%) or to schools categorized as 
“neither” (5.2%), compared to those who had attended majority black schools (2.8%). Lifetime NMUPP 
estimates for Hispanics fell between that of whites and blacks, with highest percentages among those who had 
attended predominantly white schools (12.8%) and lower numbers for those who had gone to majority black 
(10.3%) or neither majority (7.9%) schools. For those participants classified as “other” (not non-Hispanic black, 
non-Hispanic white, or Hispanic), highest prevalence of NMUPP was seen in those who had attended neither 
majority schools (12.9%), compared with 10.7% among those who had attended predominantly white schools, 
and zero among those who had gone to majority black schools in adolescence, although the number of 
participants in that subset was very small (n=20).  
 
Multilevel Results 
Multilevel Poisson regression models were run to estimate the relative risk ratios for lifetime non-medical use 
of prescription painkillers in young adulthood. Model 1 (results not presented) included only individual race: 
compared to whites, blacks had 0.28 the risk of misuse at Wave 4, Hispanics had 0.53 the risk, and those 
categorized as “other” had 0.60 the risk (p-value <0.001 for all estimates). Inclusion of individual-level 
covariates—age, sex, household income quartile in adolescence (Wave 1), and parental education—in Model 2 
(not presented) had negligible impact on the estimates for race. Estimates for parental education revealed an 
increased risk of NMUPP with higher parental educational attainment (compared to the reference group of less 
than high school), although the increased risk of the highest group (>college) was lower than that of those with 
parents only graduating from high school (RRs of 1.44 and 1.52, respectively). The effect of family income was 
not statistically significant. In Model 3 the school-level racial composition variable was added, and results 
suggested an additional protection for those who had attended a predominantly black school in adolescence 
(Table 2, RR: 0.66, p=0.03) compared to those who had gone to a predominantly white school. For our final 
models (Models 4 and 5), cross-level interactions between individual race and school racial composition were 
added. To allow for interpretation of relative NMUPP risk for each classification of participant (by individual 
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race and by type of school attended) compared to their peers, we ran two separate models in which only the 
reference group was changed: Model 4 in Table 2 displays results from models in which whites who went to 
majority white schools were assigned to be the reference group; Model 5 presents results when the same model 
was run, but with blacks who attended black schools as the reference. We present these two models because 
they enable us to directly compare NMUPP use across school categories, separately for white, black, and 
Hispanic students. Compared to blacks who had gone to majority black schools (the reference group in Model 
5), white participants who had attended majority white schools had 5.5 times the risk of later lifetime NMUPP 
reported in young adulthood (calculated by multiplying Model 5’s RR for “White” (7.20), by RR for “Majority 
White School” (2.14), by RR for interaction term, “White in White Majority School” (0.36);  p=0.01); 
compared to Hispanics from neither majority schools, whites from white schools had 2.1 times the risk of 
NMUPP (from Model 4: inverse of product of RRs for “Hispanic” (0.76), “Neither Majority School” (1.04), and 
interaction term “Hispanic in Neither Majority School” (0.59); p=0.01). Compared to blacks from black 
schools, blacks from predominantly white schools had twice the risk of prescription painkiller misuse (Model 5, 
RR for “Majority White School”: 2.14; p=0.004) over a decade later. The risk ratio comparing whites in black 
schools to whites in white schools was not significant (Model 4, RR for “Majority Black School”: 1.30; 
p=0.37). 
 
Supplemental Analysis: School-Level SES 
Supplemental Table 2 shows further breakdown of schools by school-level income across racial composition 
categories. Fifty-seven majority white schools at Wave 1 had median family incomes higher than the overall 
median income for the sample, while only one majority black school fell into that category. Low-income 
schools classified as neither majority black nor majority white far outnumbered high-income “neither” schools 
(22 vs. 8). 
 Supplemental Table 3 presents crude prevalence of NMUPP reported by participants at Wave 4, 
stratified by composition of secondary schools attended. Because only one school was classified as both high-
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income and majority black, sample numbers for that school were too low to report for non-Hispanic whites, 
Hispanics, and others. Prevalence in majority white schools and neither majority schools was higher overall in 
those schools that were high-income: 18.4% for non-Hispanic white high-income vs 14.6% non-Hispanic white 
low-income; 12.1% for neither majority high-income vs 8.7% neither majority low-income. Proportions of 
participants reporting NMUPP who had attended predominantly non-Hispanic black schools were similar for 
high-income and low-income black schools: 4.6% vs 4.5%. However, among blacks who attended majority 
black schools, crude prevalence is twice as high in high-income schools (5.8%) as in low-income schools 
(2.9%). Patterns are similar, though differences not as large, for blacks and for whites who attended majority 
white schools, though differences for Hispanics and for others are quite small: 14.7% and 13.9% in high-income 
white schools vs 14.3% and 16.7% in low-income white schools, respectively. The only evidence for any crude 
prevalence higher among those who went to low-income vs low-income schools can be seen in reports by non-
Hispanic whites who attended neither majority schools, with 19.1% from high-income schools and 21.9% from 
low-income schools reporting NMUPP. 
 
Discussion 
In our multilevel analysis following participants over fourteen years, we found evidence of a lasting influence 
of racial composition at the secondary school level on later health in young adulthood. Risk of nonmedical use 
of prescription painkillers was highest among those participants who had attended a majority white school in 
adolescence, supporting our first hypothesis. At first sight, our results might seem to suggest that in some cases, 
being in the minority group at a school is associated with higher risk of NMUPP. However, differences among 
white students from predominantly white schools versus white students from predominantly black schools were 
not statistically significant (RR: 1.30; p=0.37), possibly reflecting the small number in our sample of white 
students who had attended black schools (n=63). Future studies, however, should examine this hypothesis using 
larger samples. Our prediction that the association between school-level race and lifetime NMUPP would vary 
by individual race, therefore, could not be supported. Finally, we found evidence that blacks who attended white 
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schools had significantly higher rates of misuse than did blacks who had attended black schools. This 
association persisted nearly 15 years after participants were in their middle and high school environments.  
The multilevel nature of our analyses allows us to begin to tease out the compositional from the 
contextual effects at play. While individual-level race remains a significant predictor of NMUPP in all adjusted 
models, the school-level effect estimates indicate that factors in the school environment influence risk of 
nonmedical use of prescription painkillers over and above factors at the individual level. Our results echo the 
findings of Goosby and Walsemann [51], which revealed an association—among young black adults—between 
earlier attendance in higher percent white schools and poorer self-rated health later in young adulthood. We find 
similar evidence of apparent harm for blacks in a school environment where they are the minority, with those 
students reporting higher rates of lifetime nonmedical use of prescription painkillers. 
The exact underlying mechanisms driving the differences in reported NMUPP seen in our results are 
impossible to pin down without further analysis. The prescription drug misuse disparities by school racial 
composition might stem from the effect of (harmful) social influence of white students’ prescription misuse on 
the behavior of black students in majority-white schools [38] and from the consequences (as predicted by a 
contagion or epidemic model, [55]) of daily interaction and contact with students misusing opioids. Adolescents 
are particularly susceptible to the influence of social and behavioral norms within their schools [37]; these 
behaviors—ingrained at a formative time—are often carried over into young adulthood.  
Psychosocial pathways could also explain these disparities. While attending a predominantly white 
school might offer more resources than a black school would have allowed [51], for a black student it would 
also dramatically increase the likelihood of experiencing health-damaging racial discrimination [39]. As 
previous research has shown, blacks might therefore be more susceptible to engaging in substance use as a 
coping mechanism [42-44]. This risk seems particularly high for students who find themselves in an 
environment where NMUPP prevalence is higher and such behavior accepted as normative. 
It remains possible that school-level variation in substance use could reflect variability in school-wide 
regulations. However, this explanation seems less likely than others, given that evidence is weak for the 
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effectiveness of such policies [45], and the unlikelihood of the existence of school-based regulations 
specifically targeting prescription medication sharing and misuse. 
Perhaps the most plausible mechanism underlying the disparities in NMUPP seen in our study involves 
actual access of students to prescription drugs. A wealth of evidence points to far higher prescribing rates by 
doctors for non-Hispanic white patients compared to other racial and ethnic groups [6, 7]. In addition, at the 
neighborhood-level, pharmacies in predominantly white areas have strikingly higher stocks of opioid analgesics 
than those in minority neighborhoods [9, 10]. Since adolescents misusing prescription drugs usually gain access 
to them via friends and family [46, 47], exposure to more peers with more prescriptions would put black 
students in white schools, for example, more at risk than they would be in predominantly black schools.  
Our supplemental analysis looking at high- vs low-income schools points to a fertile area for future 
study. While our study was constrained by small sample sizes limiting subgroup analysis, there is evidence of a 
school-level SES effect as well as a racial composition effect. It would be valuable to explore whether NMUPP 
patterns vary by school-level SES, as limited research has suggested is the case for other types of substance use 
and abuse at a level higher than that of the individual. For example, analysis of results from the Department of 
Housing and Urban Development’s Moving To Opportunity randomized social experiment have indicated a 
harmful effect—among males—of moving out of Section 8 housing into assignment in a different, higher-
income neighborhood. Compared to controls, males in the treatment group reported higher rates of using 
marijuana, cigarettes, and alcohol in the last 30 days [56]. Rates among the treatment group were three times 
higher for alcohol use, and even higher for the other two substances. Opposite effects were seen for female 
participants, though not all differences were significant. 
Strengths and Limitations 
To our knowledge, this is the first study to look at school context with respect to prescription drug misuse. It is 
also the first to look at enduring associations between school racial composition and later reporting of lifetime 
non-medical use of prescription painkillers in young adulthood. The innovative nature of our study begins to fill 
a critical gap in the literature on the ongoing epidemic of prescription drugs—and particularly of opioid 
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analgesics—in this country. This analysis brings a much-needed lifecourse perspective to the investigation of 
risk factors for NMUPP above and beyond those at the individual level. Its longitudinal, multilevel nature offers 
a powerful lens that has been rare in research relying solely on cross-sectional data.  
While we believe that our study provides valuable new insight, it is not without limitations. First, our 
measures rely heavily on self-report. While Add Health strives to ensure that participants answer truthfully and 
accurately by providing more confidential means of answering sensitive questions, there is always a risk of 
inaccuracy with self-reported information. In our case, both outcome and main independent variables of interest 
rely on participant and parental self-report. However, it is more likely that substance use would be under-
reported rather than over-reported due to desirability bias. Such an error would result in underestimates in our 
associations, rather than overestimates. 
Another limitation of the data lies in the question asked about our outcome, lifetime non-medical use of 
prescription painkillers. Unfortunately, no questions were asked about the frequency or extent of misuse. Nor 
were participants queried about the reasons for their misuse of prescription drugs. This lack of detail limits the 
conclusions we might draw from our results. Questions about misuse of prescription drugs were not asked of 
participants at baseline (Wave 1, 1994/1995), so we are unable to trace any changes in misuse over time. 
Finally, we have not weighted our analyses to make our sample nationally representative. Our findings, 
therefore, can not be generalized to those beyond our sample population.  
 
Conclusions 
Our study offers early findings suggesting a lasting impact of school racial composition on students well beyond 
their years spent in school. This preliminary work highlights the need for a more in-depth, longitudinal 
examination of the possible pathways—psychosocial, material, or otherwise—that influence risk of prescription 
drug misuse at the individual and school levels that might help to inform future education and policy efforts. 
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Table 1. Weighted Crude Prevalence (%) of Add Health Participants Reporting Prescription Painkiller Misuse 
at Wave 4 (2008), by Racial Composition of School Attended at Wave 1 (1994/5) 
  
 
 
School-Level Composition (Wave 1) 
 
 
 
Overall 
(132 schools) 
>50% NHW 
(88 schools) 
>50% NHB 
(14 schools) 
Neither  
(30 schools) 
FULL SAMPLE  
 
15.8 
(n=11,176) 
17.9 
(n=7,111) 
4.8 
(n=833) 
12.4 
(n=3,232) 
 
Non-Hispanic Blacks  
 
4.2 
(n=2,229) 
5.2 
(n=708) 
2.8 
(n=726) 
5.2 
(n=795) 
Non-Hispanic Whites 
 
19.4 
(n=6,562) 
19.3 
(n=5,852) 
15.7 
(n=60) 
21.5 
(n=650) 
Hispanics 
 
9.5 
(n=1,673) 
12.8 
(n=377) 
10.3 
(n=28) 
7.9 
(n=1,268) 
Others 
 
11.1 
(n=712) 
10.7 
(n=174) 
0 
(n=19) 
12.9 
(n=519) 
 
 
 
Note: “Majority black” and “majority white” are those with school populations >50% of respective group; 
“neither” are those remaining schools. Prevalence has been weighted to correct for individuals’ probability of 
selection. 426 observations with non-positive weights were excluded from calculations. 
 
 
 
Table 2. Risk Ratios from Two-level Random Intercept Multilevel Models for Self-Reported Rx Painkiller Ever Misuse Among Add Health Participants, Wave 4 (n=11,602) 
 
  
Model 3 
 
  Model 4   
 
Model 5 
  RR 95% CI p-val RR 95% CI p-val 
 
RR 95% CI p-val 
INDIVIDUAL-LEVEL 
    
        INDIVIDUAL-LEVEL 
    White (ref) 1.00 
   
1.00       Black (ref) 1.00 
   Black 0.33 0.26 0.41 *** 0.39 0.29 0.52 *** White 7.20 3.64 14.25 *** 
Hispanic 0.59 0.48 0.73 *** 0.76 0.58 1.00 0.05 Hispanic 2.04 0.48 8.70 0.34 
Other 0.59 0.46 0.77 *** 0.69 0.46 1.03 0.07 Other - - - - 
SCHOOL-LEVEL 
    
        SCHOOL-LEVEL 
    Majority White School (ref) 1.00 
   
1.00       Maj Black School (ref) 1.00 
   Majority Black School 0.66 0.45 0.97 * 1.30 0.74 2.31 0.37 Maj White School 2.14 1.28 3.58 ** 
Neither Majority School 0.90 0.74 1.10 0.30 1.04 0.83 1.30 0.72 Neither Maj School 1.56 0.90 2.70 0.11 
CROSS-LEVEL INTERACTIONS 
   
        CROSS-LEVEL INTERACTIONS 
    White in White Majority School (ref) 
   
1.00       Black in Black Majority School (ref) 1.00 
   Black in Black Majority School 
   
0.36 0.17 0.75 * White in White Majority School 0.36 0.17 0.75 * 
Black in Neither Majority School 
   
0.70 0.44 1.11 0.13 White in Neither Majority School 0.51 0.24 1.11 0.09 
Hispanic in Black Majority School 
   
0.37 0.08 1.69 0.20 Hispanic in White Majority School 0.96 0.22 4.33 0.96 
Hispanic in Neither Majority School 
   
0.59 0.40 0.88 * Hispanic in Neither Majority School 0.82 0.18 3.68 0.80 
"Other" in Black Majority School 
   
- - - - "Other" in White Majority School - - - - 
"Other" in Neither Majority School 
   
0.73 0.43 1.24 0.25 "Other" in Neither Majority School - - - - 
 
Notes: Model 1 includes only individual race. Model 2 adjusts for individual-level covariates: sex, age, household income at Wave I, and parental education. Models 3, 4, and 5 additionally adjust for 
school-level variables: region of country, school size, and school sector (private vs. public). Model 4’s reference group is whites in white schools, while Model 5’s reference group is blacks in black 
schools, to allow for interpretation of relative risk for each classification of students. School-level variables reflect schools attended by participants at Wave 1 (1994/5). Non-medical use of 
prescription painkillers was reported at Wave 4 (2008). P-values: * <0.05; ** <0.01; *** <0.001. 
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Figure 1. Weighted Crude Prevalence (%) of Add Health Participants Reporting Ever Prescription 
Painkiller Misuse in Young Adulthood (Wave 4), by Individual Race and Racial Composition of School 
Attended (Wave 1)  
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Notes: For the three mutually exclusive school-level variables: “majority black” and “majority white” are 
those schools with populations >50% of either respective group; “neither” are those remaining schools. 
Percentages for “others” from majority non-Hispanic black schools are omitted due to small sample size 
(n=10; none reported misuse). Prevalence has been weighted to correct for individuals’ probability of 
selection. 426 observations with non-positive weights were excluded from calculations. 
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Supplemental Table 1. Unweighted Crude Prevalence (%) of Add Health Participants 
Reporting Prescription Painkiller Misuse at Wave 4 (2008), by Racial Composition of 
School Attended at Wave 1 (1994/5) 
  
 
 
School-Level Composition (Wave 1) 
 
 
 
Overall 
(132 schools) 
>50% NHW 
(88 schools) 
>50% NHB 
(14 schools) 
Neither  
(30 schools) 
FULL SAMPLE  
 
14.1 
(n=11,602) 
17.2 
(n=7,377) 
4.5 
(n=888) 
9.7 
(n=3337) 
 
Non-Hispanic Blacks  
 
4.9 
(n=2,347) 
7.0 
(n=748) 
3.1 
(n=775) 
4.9 
(n=824) 
Non-Hispanic Whites 
 
19.0 
(n=6798) 
18.7 
(n=6056) 
22.2 
(n=63) 
20.8 
(n=679) 
Hispanics 
 
8.7 
(n=1722) 
14.6 
(n=391) 
6.7 
(n=30) 
7.0 
(n=1301) 
Others 
 
10.5 
(n=735) 
13.7 
(n=182) 
0 
(n=20) 
9.8 
(n=533) 
 
 
 
Note: “Majority black” and “majority white” are those with school populations >50% of 
respective group; “neither” are those remaining schools. 
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Supplemental Table 2. Breakdown of 132 Schools by Racial Composition and School-Wide 
Income (Wave 1, 1994/5) 
 
 
 
 
 
 
 
 
Note: For the cut-off for high- vs low-income schools, the median across schools of median per-
person household income is used. “Majority black” and “majority white” are those with school 
populations >50% of respective group; “neither” are those remaining schools. 
 
 
 
 
Supplemental Table 3. Crude Prevalence (%) Students Reporting Prescription Painkiller Misuse 
at Wave 4, By Wave 1 School Racial Composition and High- vs Low-Income School 
 
 
 >50% Non-Hispanic 
Black 
>50% Non-Hispanic White Neither 
 4.5% N=888 17.2% N=7377 9.7% N=3337 
 High-
Income 
(n=66) 
Low-
Income 
(n=822) 
High-
Income 
(n=5068) 
Low-Income 
(n=2309) 
High-
Income 
(n=980) 
Low-
Income 
(n=2357) 
Overall 4.6 4.5 18.4 14.6 12.1 8.7 
Non-Hispanic 
Black 
5.8 2.9 8.7 5.4 5.4 4.5 
Non-Hispanic 
White 
- 22.2 19.6 16.7 19.1 21.9 
Hispanics - 8.3 14.7 14.3 10.5 6.7 
Others - - 13.9 13.3 14.7 6.0 
 
Overall high-income=17.2; overall low-income=10.6. 
 
Note: For the cut-off for high- vs low-income schools, the median across schools of median per-person 
household income was used. “Majority black” and “majority white” are those with school populations 
>50% of respective group; “neither” are those remaining schools. Percentages for “others” from majority 
non-Hispanic black schools are omitted due to very small sample sizes (from high-income schools: n=8; 
low-income schools: 12; all reported no misuse), as is the prevalence for Hispanics from high-income 
majority black schools (n=6; none reported misuse). 
 
 
High-Income (66) Low-Income (66) 
Majority Black (14) 1 13 
Majority White (88) 57 31 
Neither (30) 8 22 
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Supplemental Figure 1. Unweighted Crude Prevalence (%) of Add Health Participants Reporting Ever 
Prescription Painkiller Misuse in Young Adulthood (Wave 4), by Individual Race and Racial 
Composition of School Attended (Wave 1)  
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Notes: For the three mutually exclusive school-level variables: “majority black” and “majority white” are 
those schools with populations >50% of either respective group; “neither” are those remaining schools. 
Percentages for “others” from majority non-Hispanic black schools are omitted due to small sample size 
(n=10; none reported misuse). 
 
 
